Clinical Outcomes, Graft Longevity, and Chondral Protection Following Primary or Revision Meniscal Allograft Transplantation Surgery

Launched by JOINT RESTORATION FOUNDATION, INC. · Dec 18, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Subjects enrolled in this study must meet all of the following inclusion criteria:
• • Males and females aged 10-65 years
• • MRI or arthroscopic images confirming the suitability for meniscus transplantation.
• • Patients undergoing an isolated primary/revision MAT (meniscal allograft transplant) procedure, or concomitant MAT with other knee procedures such as ligament reconstruction, realignment osteotomy, or cartilage resurfacing.
• • Medically suitable for meniscus transplantation.
• • Appropriate understanding of the language of the surgical center in terms of communication and reading.
• • Ability of the Patient or parent/guardian to provide informed consent.
• Exclusion Criteria:
• • Inability to comply with rehabilitation programs.
• • Patient aged less than 10 years and more than 65.
• • Presence of diffuse full thickness cartilage loss (widespread ICRS Grade III-IV chondral damage) and/or architectural remodeling of bone (i.e. flattening of condyle) in the knee of interest.
• • Significant medical comorbidities that limit patients from undergoing surgery.
• • Presence of confounding neuromuscular, genetic/congenital, or post-traumatic conditions.